Vertex Pharmaceuticals Inc
XETRA:VX1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Vertex Pharmaceuticals Inc
XETRA:VX1
|
US |
|
Tencent Holdings Ltd
HKEX:700
|
CN |
|
S
|
Schneider Electric SE
XBER:SND
|
FR |
|
S
|
Stora Enso Oyj
XBER:ENUA
|
FI |
|
A
|
Adecco Group AG
SIX:ADEN
|
CH |
|
Caltagirone SpA
LSE:0OIY
|
IT |
|
SB Financial Group Inc
NASDAQ:SBFG
|
US |
|
P
|
Pan Pacific International Holdings Corp
F:QJE
|
JP |
|
H
|
Hongkong Land Holdings Ltd
F:HLH
|
BM |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Benefit Systems SA
F:3ZV
|
PL |
|
Boeing Co
NYSE:BA
|
US |
Wall St Price Targets
VX1 Price Targets Summary
Vertex Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for VX1 is 488.77 EUR with a low forecast of 290.46 EUR and a high forecast of 586.54 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is VX1's stock price target?
Price Target
488.77
EUR
According to Wall Street analysts, the average 1-year price target for VX1 is 488.77 EUR with a low forecast of 290.46 EUR and a high forecast of 586.54 EUR.
What is the Revenue forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 3 years is 10%.
What is the Gross Profit forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 17%. The projected CAGR for the next 3 years is 11%.
What is the Operating Income forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Operating Income has been 42%. The projected CAGR for the next 3 years is 17%.
What is the Pre-Tax Income forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
20%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 47%. The projected CAGR for the next 3 years is 20%.
What is the Net Income forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
18%
The compound annual growth rate for Net Income over the next 3 years is 18%.
